RxDoctor Payments Data

Margaret Purdy

Internal Medicine · Owosso, MINPI 1366411100

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by GSK at 27.0% of the total. Reporting peaked in 2020 at $515 and has fallen 95.6% since, to $23 in 2024.

$1,269in general payments, 2019–2025

Across 83 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$343
  • AstraZeneca$211
  • Boehringer Ingelheim$206
  • Johnson & Johnson$93
  • Amarin Pharma, Inc.$55
  • Actelion Pharmaceuticals US, Inc.$44
  • plus $317 from 14 others

What the payments were for

  • Food & beverage$1,269100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,269 in reported general payments places this provider in the 75th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan →

Other internal medicine in Owosso

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →